HLA 1 & 2 Donor HLA Tissue Typing Test at Lahore PCR Lab

HLA 1 & 2 (Donor) HLA Tissue Typing at Lahore PCR Lab

Human Leukocyte Antigen (HLA) typing, also known as tissue typing, is a highly specialized molecular laboratory procedure used to identify specific genetic markers on the surface of immune cells. These markers, encoded by the Major Histocompatibility Complex (MHC) gene family on chromosome 6, play a critical role in the body’s immune response by distinguishing self from non-self. The HLA system is broadly categorized into Class I (comprising HLA-A, HLA-B, and HLA-C loci) and Class II (comprising HLA-DR, HLA-DQ, and HLA-DP loci). The HLA 1 & 2 (Donor) HLA Tissue Typing test at Lahore PCR Lab is an essential diagnostic tool designed to analyze these loci in potential donors. This test is primarily utilized in transplant medicine to evaluate the immunological compatibility between a donor and a recipient, thereby minimizing the risk of post-transplant complications such as graft rejection and graft-versus-host disease (GVHD).

At Lahore PCR Lab, located in Lahore, Pakistan, this complex genetic analysis is performed using advanced molecular biology techniques, including Polymerase Chain Reaction (PCR) with Sequence-Specific Primers (PCR-SSP) or Sequence-Specific Oligonucleotides (PCR-SSO). This state-of-the-art molecular technology provides high-resolution typing, allowing clinical specialists to identify specific HLA alleles with exceptional precision. Unlike older serological methods, molecular HLA typing detects the exact nucleotide sequences of the HLA genes, offering unparalleled diagnostic value. This level of detail is critical for both solid organ transplantation (such as kidney and liver transplants) and hematopoietic stem cell or bone marrow transplantation. By establishing a precise genetic profile of the donor, transplant teams can make highly informed decisions, optimize immunosuppressive therapy, and significantly improve long-term patient and graft survival rates.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure sample integrity and accurate molecular analysis. Patients undergoing the HLA 1 & 2 (Donor) HLA Tissue Typing test at Lahore PCR Lab should follow these guidelines:

• No Fasting Required: There is no need to fast before this test. You may eat and drink normally prior to your appointment.
• Medication History: Inform your healthcare provider about all current medications, especially immunosuppressants or chemotherapy drugs, as these can impact overall clinical evaluation.
• Blood Transfusion History: It is critical to notify the laboratory if you have received a blood transfusion within the last three months, as donor white blood cells can temporarily interfere with molecular typing results.
• Prior Transplants: Inform the lab if you have previously undergone a bone marrow or stem cell transplant, as this significantly affects the genetic profile present in your blood.
• Hydration: Ensure you are well-hydrated before the blood draw, as this makes the venipuncture procedure easier and more comfortable.
• Identification: Bring valid identification and any transplant coordination documents provided by your clinical team to ensure accurate donor-recipient matching records.

During the Procedure

The HLA tissue typing procedure involves a standard blood draw (venipuncture) performed by a trained phlebotomist. Here is what you can expect during your visit to Lahore PCR Lab:

• Patient Positioning: You will be asked to sit comfortably in a blood collection chair. The phlebotomist will examine your arm to locate a suitable vein, typically in the crease of the elbow.
• Aseptic Technique: The skin over the selected vein is thoroughly cleansed with an antiseptic solution to prevent contamination of the sample and protect you from infection.
• Equipment and Sample Collection: A sterile, single-use needle attached to a vacuum collection tube containing an anticoagulant (usually EDTA) is inserted into the vein. The blood is drawn directly into the tube.
• Duration: The actual blood draw takes less than two minutes. The entire process, including registration and preparation, is completed within fifteen minutes.
• Patient Experience: You may feel a brief, mild pinch or stinging sensation when the needle is inserted. Some minor bruising or soreness at the injection site may occur afterward, which typically resolves quickly.
• Safety Considerations: Lahore PCR Lab adheres to strict biosafety protocols. All needles and collection devices are sterile, single-use, and disposed of immediately in biohazard containers to ensure complete patient safety.

When is a HLA 1 & 2 (Donor) HLA Tissue Typing Performed?

Renal and Solid Organ Transplantation

Physicians request HLA tissue typing for potential living donors during the pre-transplant workup for solid organ transplants, most commonly kidney and liver transplantations. In patients with end-stage renal disease or chronic liver failure, finding a compatible donor is vital. The test identifies the degree of HLA mismatch between the donor and the recipient. A lower number of mismatches reduces the likelihood of the recipient’s immune system recognizing the donor organ as foreign, thereby preventing acute or chronic graft rejection and reducing the patient’s dependence on high-dose immunosuppressive medications.

Hematopoietic Stem Cell and Bone Marrow Transplantation

For patients suffering from hematological malignancies such as leukemia, lymphoma, or severe hematological disorders like aplastic anemia, an allogeneic hematopoietic stem cell transplant is often a curative option. In these cases, HLA matching is exceptionally critical. Physicians order high-resolution HLA Class I and Class II typing for potential bone marrow donors. A precise match is required to prevent Graft-versus-Host Disease (GVHD), a life-threatening condition where the donor’s immune cells attack the recipient’s healthy tissues, and to ensure successful engraftment of the stem cells.

Platelet Transfusion Refractoriness

Patients with severe thrombocytopenia who receive multiple platelet transfusions may develop antibodies against foreign HLA antigens, a condition known as HLA alloimmunization. When this occurs, standard platelet transfusions fail to increase the patient’s platelet count, leading to platelet refractoriness and an increased risk of severe bleeding. Hematologists request HLA tissue typing for both the patient and potential platelet donors to identify HLA-matched platelets, ensuring that the transfused platelets are not rapidly destroyed by the patient’s immune system.

Autoimmune Disease Association Studies

Certain HLA alleles are strongly associated with a genetic predisposition to specific autoimmune and inflammatory diseases. For instance, HLA-B*27 is linked to ankylosing spondylitis, while HLA-DQ2 and HLA-DQ8 are associated with celiac disease. When patients present with chronic joint pain, spinal stiffness, or gastrointestinal malabsorption symptoms, rheumatologists and gastroenterologists may request HLA typing to assist in confirming a diagnosis, ruling out other conditions, or assessing genetic risk factors in families.

Hypersensitivity and Drug Reaction Screening

Severe, life-threatening drug hypersensitivity reactions, such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), are associated with specific HLA alleles. For example, the HLA-B*57:01 allele is a strong predictor of hypersensitivity to the antiretroviral drug abacavir, and HLA-B*15:02 is linked to carbamazepine-induced SJS. Before initiating these therapies, physicians order HLA typing to screen patients and donors, allowing them to avoid prescribing medications that could trigger severe, genetically mediated adverse drug reactions.

What Does a HLA 1 & 2 (Donor) HLA Tissue Typing Detect?

The HLA 1 & 2 (Donor) HLA Tissue Typing test is designed to detect and identify specific molecular markers and genetic variations. Specifically, this test detects:

• HLA-A Alleles: Identifies specific genetic variants at the HLA-A locus, which is a key component of Class I histocompatibility.
• HLA-B Alleles: Detects highly polymorphic variants at the HLA-B locus, critical for both transplant matching and disease association.
• HLA-C Alleles: Determines the alleles present at the HLA-C locus, which plays a role in natural killer (NK) cell regulation.
• HLA-DRB1 Alleles: Identifies the primary Class II HLA genes, which are highly immunogenic and crucial for bone marrow transplant success.
• HLA-DQB1 Alleles: Detects specific Class II alleles that influence immune response and transplant compatibility.
• HLA-DQA1 Alleles: Evaluates additional Class II genetic markers to provide a comprehensive tissue typing profile.
• HLA-DPB1 Alleles: Identifies DP beta chain alleles, useful in high-resolution matching for stem cell transplants.
• High-Resolution Allele Matching: Determines the exact DNA sequence of the HLA genes, distinguishing subtle nucleotide differences.
• Low-Resolution Antigen Matching: Identifies the broad serological antigen groups, useful for initial solid organ donor screening.
• Degree of Histocompatibility Mismatch: Quantifies the exact number of HLA mismatches between the donor and the recipient.
• HLA-B*27 Allele: Specifically detects this marker associated with ankylosing spondylitis and acute anterior uveitis.
• HLA-B*57:01 Allele: Screens for the genetic marker indicating high risk for abacavir hypersensitivity.
• HLA-B*15:02 Allele: Detects the marker associated with severe carbamazepine-induced cutaneous reactions.
• HLA-DQ2 and HLA-DQ8 Alleles: Identifies the genetic markers associated with celiac disease susceptibility.
• HLA-DR4 Allele: Detects genetic susceptibility markers linked to rheumatoid arthritis.
• Haploidentical Match Status: Determines if a family member is a half-match (5/10), which is valuable for haploidentical stem cell transplants.
• Homozygosity at HLA Loci: Identifies whether the donor carries identical alleles on both chromosomes for a specific locus.
• Rare HLA Phenotypes: Detects uncommon HLA combinations that may require specialized donor registries.
• Donor-Specific Antigen Targets: Identifies HLA antigens in the donor that could react with pre-existing antibodies in the recipient.
• Genetic Lineage Markers: Provides detailed immunogenetic data useful for family studies and lineage tracing.
• DNA Integrity and Quality: Assesses the quality of the extracted genomic DNA to ensure the validity of the PCR amplification.
• Chimerism Baseline: Establishes the donor’s genetic baseline, which is critical for monitoring post-transplant donor chimerism.

Turnaround Time and Report Access at Lahore PCR Lab

Because HLA tissue typing is a highly complex molecular diagnostic procedure involving DNA extraction, PCR amplification, and detailed genetic analysis, the turnaround time is longer than standard blood tests. At Lahore PCR Lab, we prioritize accuracy, clinical safety, and stringent quality control. The testing process is typically completed within several working days, depending on the specific resolution (low or high) required by your transplant team.

Once the analysis is complete, the results are reviewed and signed off by a consultant pathologist specializing in molecular genetics. Lahore PCR Lab offers convenient digital report access. Patients and referring physicians can securely download reports directly from our official website or patient portal. Additionally, physical copies of the reports can be collected from our main facility in Lahore. We ensure that your transplant coordination team receives these critical results promptly to avoid any delays in your treatment planning.

HLA 1 & 2 (Donor) HLA Tissue Typing Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
HLA-A Locus (Class I)	Detection of standard HLA-A alleles consistent with genetic background.	Identification of mismatched HLA-A alleles relative to the recipient.
HLA-B Locus (Class I)	Detection of expected HLA-B alleles without disease-associated mutations.	Presence of mismatched alleles or specific disease-linked alleles (e.g., HLA-B*27).
HLA-C Locus (Class I)	Normal expression of standard HLA-C alleles.	Mismatched HLA-C alleles, increasing the risk of graft rejection.
HLA-DRB1 Locus (Class II)	Detection of standard HLA-DRB1 alleles.	Mismatched HLA-DRB1 alleles, highly critical for transplant compatibility.
HLA-DQB1 Locus (Class II)	Normal HLA-DQB1 allele identification.	Presence of celiac-associated alleles (DQ2/DQ8) or donor-recipient mismatches.
Histocompatibility Match Grade	High-resolution match (e.g., 10/10 or 8/8 allele match for stem cells).	Low-resolution or partial match (e.g., 4/6 or 5/10 mismatch), indicating high rejection risk.
Antibody Target Identification	No matching donor-specific antigens that react with recipient antibodies.	Presence of donor HLA antigens that correspond to pre-existing recipient donor-specific antibodies (DSA).
Sample DNA Quality	High-purity genomic DNA extracted from nucleated blood cells.	Degraded DNA or insufficient sample volume, requiring a repeat blood draw.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for HLA 1 & 2 (Donor) HLA Tissue Typing?

• Experienced Healthcare Professionals: Our team includes highly qualified molecular biologists and consultant pathologists with extensive experience in immunogenetics.
• Patient-Focused Care: We prioritize patient comfort and clear communication, ensuring a seamless and stress-free testing experience.
• Quality Diagnostic Services: Lahore PCR Lab adheres to strict international quality control standards to deliver highly precise molecular results.
• Professional Reporting: Our reports are detailed, comprehensive, and reviewed thoroughly by specialists to ensure clinical accuracy.
• Modern Diagnostic Approach: We utilize state-of-the-art PCR technology and advanced molecular assays for high-resolution HLA typing.
• Comfortable Environment: Our diagnostic center in Lahore provides a clean, hygienic, and comfortable environment for all patients and donors.
• Convenient Location: Located centrally in Lahore, Pakistan, our facility is easily accessible for patients from all parts of the city.
• Commitment to Accurate Diagnosis: We understand the critical nature of transplant diagnostics and are committed to providing reliable, timely results to support your healthcare journey.